Your browser doesn't support javascript.
loading
Plasma miRNA profile at COVID-19 onset predicts severity status and mortality.
Fernández-Pato, Asier; Virseda-Berdices, Ana; Resino, Salvador; Ryan, Pablo; Martínez-González, Oscar; Pérez-García, Felipe; Martin-Vicente, María; Valle-Millares, Daniel; Brochado-Kith, Oscar; Blancas, Rafael; Martínez, Amalia; Ceballos, Francisco C; Bartolome-Sánchez, Sofía; Vidal-Alcántara, Erick Joan; Alonso, David; Blanca-López, Natalia; Ramirez Martinez-Acitores, Ignacio; Martin-Pedraza, Laura; Jiménez-Sousa, María Ángeles; Fernández-Rodríguez, Amanda.
Afiliación
  • Fernández-Pato A; Unit of Viral Infection and Immunity, National Center for Microbiology (CNM), Health Institute Carlos III (ISCIII), Madrid, Spain.
  • Virseda-Berdices A; Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Resino S; Unit of Viral Infection and Immunity, National Center for Microbiology (CNM), Health Institute Carlos III (ISCIII), Madrid, Spain.
  • Ryan P; Unit of Viral Infection and Immunity, National Center for Microbiology (CNM), Health Institute Carlos III (ISCIII), Madrid, Spain.
  • Martínez-González O; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain.
  • Pérez-García F; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain.
  • Martin-Vicente M; Department of Infectious Diseases, Hospital Universitario Infanta Leonor, Madrid, Spain.
  • Valle-Millares D; School of Medicine, Complutense University of Madrid, Madrid, Spain.
  • Brochado-Kith O; Gregorio Marañón Health Research Institute, Madrid, Spain.
  • Blancas R; Critical Care Department, Hospital Universitario del Tajo, Aranjuez, Spain.
  • Martínez A; Clinical Microbiology Department, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Spain.
  • Ceballos FC; Department of Biomedicine and Biotechnology, Faculty of Medicine, University of Alcalá de Henares, Madrid, Spain.
  • Bartolome-Sánchez S; Unit of Viral Infection and Immunity, National Center for Microbiology (CNM), Health Institute Carlos III (ISCIII), Madrid, Spain.
  • Vidal-Alcántara EJ; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain.
  • Alonso D; Unit of Viral Infection and Immunity, National Center for Microbiology (CNM), Health Institute Carlos III (ISCIII), Madrid, Spain.
  • Blanca-López N; Unit of Viral Infection and Immunity, National Center for Microbiology (CNM), Health Institute Carlos III (ISCIII), Madrid, Spain.
  • Ramirez Martinez-Acitores I; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain.
  • Martin-Pedraza L; Critical Care Department, Hospital Universitario del Tajo, Aranjuez, Spain.
  • Jiménez-Sousa MÁ; Department of Infectious Diseases, Hospital Universitario Infanta Leonor, Madrid, Spain.
  • Fernández-Rodríguez A; Unit of Viral Infection and Immunity, National Center for Microbiology (CNM), Health Institute Carlos III (ISCIII), Madrid, Spain.
Emerg Microbes Infect ; 11(1): 676-688, 2022 Dec.
Article en En | MEDLINE | ID: mdl-35130828

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: MicroARNs / COVID-19 Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Emerg Microbes Infect Año: 2022 Tipo del documento: Article País de afiliación: España Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: MicroARNs / COVID-19 Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Emerg Microbes Infect Año: 2022 Tipo del documento: Article País de afiliación: España Pais de publicación: Estados Unidos